ProCE Banner Events

Updates in Targeting IDH1 in Relapsed/Refractory AML

Join Dr Jorge Cortes for a review of the emerging data on the use of targeted therapy for patients with relapsed/refractory acute myeloid leukemia with IDH1 mutations including data presented at EHA 2024! This presentation will discuss new data sets, including information on treatment sequencing and difficult-to-treat populations, and their potential impacts on clinical decision-making. An interactive Q&A with Dr Cortes will follow the presentation.

Key Takeaways:

  • Review updated data for patients with R/R AML with IDH1 mutations
  • Understand the management of R/R AML with IDH1 mutations

This event has expired. No longer available for credits.

Time and location

Wednesday, August 21, 2024

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual

Faculty
Jorge E. Cortes, MD

Professor of Medicine
Director, Georgia Cancer Center
Cecil F. Whitaker Jr., GRA Eminent Scholar Chair in Cancer
Augusta University
Augusta, Georgia